The industry is entering a new phase — one where biotechnology does not replace nature, but enhances it.This is where biotech goes beyond.
Beyond sustainability claims, beyond the “natural vs synthetic” debate, and beyond traditional sourcing limitations.
It introduces a new paradigm: nature, engineered for performance.
For decades, natural has been one of the most powerful narratives in personal care. Plant-based ingredients have shaped product development, consumer perception, and formulation philosophy across categories. But today, the definition of natural is evolving.
The industry is entering a new phase — one where biotechnology does not replace nature, but enhances it.
This shift reflects a growing challenge formulators know well: traditional botanical sourcing often comes with variability. Differences in climate, soil conditions, and extraction processes can impact consistency, stability, and ultimately, performance. As formulations become more targeted and efficacy-driven, this variability becomes a limiting factor.
Biotechnology offers a new approach.
Rather than relying solely on extraction from plants, biotech enables the cultivation of actives under controlled conditions. Through precision-grown processes, it becomes possible to reproduce and enhance the most beneficial compounds found in nature — ensuring greater potency, consistency, traceability, and scalability.
This is where biotech goes beyond.
Beyond sustainability claims, beyond the “natural vs synthetic” debate, and beyond traditional sourcing limitations.
It introduces a new paradigm: nature, engineered for performance.
For formulators, this opens new possibilities.
Actives can be designed to interact with specific biological pathways, delivering measurable outcomes at lower inclusion levels. Stability profiles improve, formulation challenges are reduced, and multifunctionality becomes more accessible with a single ingredient.
For brands, the narrative evolves from “inspired by nature” to “powered by science, rooted in nature.” Consumers are increasingly receptive to this convergence, especially as transparency around sourcing, efficacy, and environmental impact becomes more important in purchasing decisions.
Importantly, biotech also supports a more responsible supply chain. By reducing dependence on large-scale harvesting, it helps preserve biodiversity while enabling year-round production of high-quality actives. This balance between innovation and sustainability is becoming a key differentiator in the next generation of ingredients.
The result is not a departure from natural — but its next iteration. In fact, the production of lab-based plant actives does not require fertilizers, pesticides, or harsh chemicals. In this sense, they can be considered not only more controlled, but also cleaner and safer to use.
From plant-based to precision-grown, the industry is moving toward a model where performance, consistency, and sustainability coexist.
In this new landscape, the question is no longer whether biotech fits within the natural narrative — but how far it can take it.
One example of this evolution can be seen in plant stem cell-derived actives such as All In One™, developed through biotechnology to deliver targeted, multifunctional benefits. By combining precision cultivation with nature-derived biology, this type of ingredient supports skin smoothing, hydration, microbiome balance, barrier reinforcement, and anti-inflammatory pathways — all within a single active.
This convergence of efficacy and simplicity reflects the broader direction of the industry: fewer ingredients, smarter functionality, and performance rooted in both nature and science.
Biotech, in this context, doesn’t move beyond nature — it unlocks its full potential.
